Therefore, the combination of serum occludin levels (representing the extent of BBB disruption) and NIHSS score (reflecting stroke severity) markedly increased the predictive value for HT, providing a new method for predicting HT in stroke patients with reperfusion therapy. The gene discussed is OCLN; the disease is Stroke.